Direct costs of glaucoma management following initiation of medical therapy

@article{Kobelt1998DirectCO,
  title={Direct costs of glaucoma management following initiation of medical therapy
},
  author={Gisela Kobelt and Linus J{\"o}nsson and Ulf-G. Gerdtham and G{\"u}nter Karl Krieglstein},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={1998},
  volume={236},
  pages={811-821}
}
Abstract ·Background: Economic evaluation of new treatments in the field of glaucoma represents a challenge. In the absence of a clear epidemiological link between intra-ocular pressure (IOP) and disease progression to blindness, the economic impact of treatments that lower IOP on long-term outcome cannot be estimated. As an alternative, effectiveness may be expressed as the ability to control IOP over time, making it possible to estimate the cost-effectiveness of therapies. The objective of… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

The Economic Implications of Glaucoma

VIEW 4 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Modeling cost and cost-effectiveness of new treatments for glaucoma

G Kobelt, L Jönsson
  • Int J Med Technol Assessment
  • 1998
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Grunddaten zur kassenärztlichen vertragsärztlichen Versorgung

JM Tielsch, A Sommer, J Katz
  • 1997

Methods for the economic evaluation of health care programmes, 2nd edn

MF Drummond, B O'Brien, GL Stoddart, GW Torrance
  • 1997
VIEW 1 EXCERPT

Observational costing study in open angle primary glaucoma: results for Canada

UG Gerdtham, T Williamson, A Hågå, G Kobelt, B Jönsson
  • EFI Research Paper no
  • 1997
VIEW 2 EXCERPTS

Observational costing study in open angle primary glaucoma in Sweden and the USA

UG Gerdtham, A Hågå, G Karlsson, G Kobelt, B Jönsson
  • EFI Research Paper no
  • 1996
VIEW 2 EXCERPTS

Re : Solve 500 data model , glaucoma drug claims , December 1 , 1995 to December 31 , 1997

B Rittenhouse
  • Uses of models in economic evaluations of medicines and other health technologies
  • 1996

Theory and methods of economic evaluation of health care.

  • Developments in health economics and public policy
  • 1996
VIEW 1 EXCERPT